In vitro release and the liver targeting of oxymatrine polybutylcyanoacrylate nanoparticles

Journal of China Pharmaceutical University

Volumn 41, Issue 6, 2010, Pages 520-523

  Ge, Liang ^a   Lu, Man ^a   Chen, Yue Jian ^a   Chen, Yan Hua ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Liver targeting; Nanoparticle; Oxymatrine; Polybutylcyanoacrylate; Release in vitro

Indexed keywords

NANOPARTICLE; OXYMATRINE; OXYMATRINE POLYBUTYLCYANOACRYLATE NANOPARTICLE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; DRUG TARGETING; IN VITRO STUDY; LIVER; MOUSE; NONHUMAN; SUSTAINED DRUG RELEASE; TISSUE DISTRIBUTION;

EID: 78651273485     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Douglas SJ, Illum L, Davis SS. Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles[J]. J Colloid Inter Sci, 1985,103:154.
2. (Li D), (Wang PQ), (Zhang NS). (Chin Tradit Herb Drugs), 1996,27(5):308-311.
3. (Zhao YY), (Zhang RY). (Nat Prod Res Dev),1991,3 (3):93-103.
4. (Chen JY), (He WY), (Zhou GL), (Chin Pharm Bull),1983,18(3):407-409.
5. (Gan WL), (Wang GJ), (Li YL). Tradit Herb Drugs),2002,33(4):339-341.
6. Liu J, Liu Y, Klaassen CD. The effect of Chinese hepatoprotective medicines on experimental liver injury in mice[J]. J Ethnopharmacol, 1994,42(3):183-191.
7. (Lu M), (Zhu JB), (Shi ZY). (Jiangsu Pharm Clin Res) ,2006,14(2):7.
8. Wohlgemuth M, Machtle W, Mayer C. Improved preparation and physical studies of polybutylcyanoacrylate nanocapsules [J]. J Microencapsul,2000,17(4): 437.
9. (Menggen DL), (Wang Y), (Shi Y). (Chin J Pharm Anal) ,1999,19(2):114-117.
10. (Liao GT). 1997:228-234.